12 Health Care Stocks Moving In Friday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Friday's after-market session, several healthcare stocks showed notable movements. Bluejay Diagnostics, China Pharma Holdings, and Imunon were among the top gainers, with increases of 11.0%, 10.15%, and 7.63% respectively. On the losing end, Compass Therapeutics, Akanda, and Portage Biotech saw significant declines. Accolade also rose by 5.83% following their Q4 earnings release.
April 26, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Akanda's shares fell by 7.77% to $0.1, with a market cap of $1.1 million.
Akanda's stock price drop suggests a negative reaction from investors, possibly due to adverse events or market conditions.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 90
NEGATIVE IMPACT
Compass Therapeutics stock decreased by 8.3% to $1.33, with a market cap of $182.9 million.
The decline in Compass Therapeutics' stock price could be due to negative market sentiment or disappointing company news.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Accolade's shares rose by 5.83% to $8.35 following their Q4 earnings release, with a market cap of $646.3 million.
The positive movement in Accolade's stock price post-earnings suggests the market reacted favorably to their Q4 results.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 95
POSITIVE IMPACT
Bluejay Diagnostics saw an 11.0% increase to $0.73, with a market cap of $1.9 million.
The significant after-market gain suggests positive investor sentiment, potentially due to unmentioned catalysts or broader market trends.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
China Pharma Holdings' stock rose by 10.15% to $0.33.
The rise in stock price could indicate positive market reaction to industry or company-specific news not detailed in the article.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 90
POSITIVE IMPACT
Imunon's shares increased by 7.63% to $1.55, with a market cap of $14.5 million.
The increase in Imunon's stock price may reflect investor optimism or reactions to recent company developments.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90